rs45478892

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000548.5(TSC2):​c.1281C>A​(p.Ile427Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,611,964 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. I427I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0019 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 10 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:24O:2

Conservation

PhyloP100: -0.178

Publications

7 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 16-2062520-C-A is Benign according to our data. Variant chr16-2062520-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 49685.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.178 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00191 (291/152352) while in subpopulation NFE AF = 0.00332 (226/68030). AF 95% confidence interval is 0.00297. There are 2 homozygotes in GnomAd4. There are 129 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 291 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.1281C>Ap.Ile427Ile
synonymous
Exon 13 of 42NP_000539.2P49815-1
TSC2
NM_001406663.1
c.1281C>Ap.Ile427Ile
synonymous
Exon 13 of 42NP_001393592.1A0A2R8Y6C9
TSC2
NM_001114382.3
c.1281C>Ap.Ile427Ile
synonymous
Exon 13 of 41NP_001107854.1P49815-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.1281C>Ap.Ile427Ile
synonymous
Exon 13 of 42ENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.1281C>Ap.Ile427Ile
synonymous
Exon 13 of 41ENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.1281C>Ap.Ile427Ile
synonymous
Exon 13 of 40ENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
AF:
0.00191
AC:
291
AN:
152234
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00332
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00175
AC:
433
AN:
246874
AF XY:
0.00168
show subpopulations
Gnomad AFR exome
AF:
0.000446
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.00222
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00113
Gnomad NFE exome
AF:
0.00282
Gnomad OTH exome
AF:
0.00331
GnomAD4 exome
AF:
0.00311
AC:
4542
AN:
1459612
Hom.:
10
Cov.:
31
AF XY:
0.00295
AC XY:
2140
AN XY:
725788
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33460
American (AMR)
AF:
0.00157
AC:
70
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
0.00227
AC:
59
AN:
26048
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.000117
AC:
10
AN:
85570
European-Finnish (FIN)
AF:
0.00135
AC:
72
AN:
53234
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5760
European-Non Finnish (NFE)
AF:
0.00375
AC:
4166
AN:
1111020
Other (OTH)
AF:
0.00242
AC:
146
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
219
438
656
875
1094
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00191
AC:
291
AN:
152352
Hom.:
2
Cov.:
33
AF XY:
0.00173
AC XY:
129
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000649
AC:
27
AN:
41584
American (AMR)
AF:
0.00105
AC:
16
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00332
AC:
226
AN:
68030
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00326
Hom.:
0
Bravo
AF:
0.00186
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00322
EpiControl
AF:
0.00279

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not provided (7)
-
-
6
not specified (6)
-
-
5
Tuberous sclerosis 2 (5)
-
-
3
Tuberous sclerosis syndrome (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 (1)
-
-
-
Lymphangiomyomatosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
2.8
DANN
Benign
0.61
PhyloP100
-0.18
PromoterAI
0.00060
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45478892; hg19: chr16-2112521; COSMIC: COSV104587061; API